A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

QR Code

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

Here the authors report the isolation and structural and biological characterization of a humanized angiotensin-converting enzyme 2 (ACE2)-blocking antibody, which exterts potent inhibitory activity against SARS-CoV and circulating global SARS-CoV-2 lineages both in vitro and in hACE2 mouse model.

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yanyun Du, Rui Shi, Ying Zhang, Xiaomin Duan, Li Li, Jing Zhang, Fengze Wang, Ruixue Zhang, Hao Shen, Yue Wang, Zheng Wu, Qianwen Peng, Ting Pan, Wanwei Sun, Weijin Huang, Yue Feng, Hui Feng, Junyu Xiao, Wenjie Tan, Youchun Wang, Chenhui Wang, Jinghua Yan
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Science Q
Accès en ligne:	https://doaj.org/article/97a9b5fb5db54f02ba7db4036da85f1f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
par: Jiwan Ge, et autres
Publié: (2021)

A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
par: Zhenlin Yang, et autres
Publié: (2021)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
par: Changhai Lei, et autres
Publié: (2020)

The molecular basis for SARS-CoV-2 binding to dog ACE2
par: Zengyuan Zhang, et autres
Publié: (2021)

A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
par: Qingrui Huang, et autres
Publié: (2021)

Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
par: Qingrui Huang, et autres
Publié: (2021)

High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
par: Chao Liu, et autres
Publié: (2021)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
par: Shiho Tanaka, et autres
Publié: (2021)

Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2
par: Georgina I. López-Cortés, et autres
Publié: (2021)

TAGAP instructs Th17 differentiation by bridging Dectin activation to EPHB2 signaling in innate antifungal response
par: Jianwen Chen, et autres
Publié: (2020)

A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection
par: Ami Miller, et autres
Publié: (2021)

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
par: Ivan T. Lee, et autres
Publié: (2020)

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
par: Xing Zhu, et autres
Publié: (2021)

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
par: Shuang Wang, et autres
Publié: (2020)

The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies.
par: Devin Sok, et autres
Publié: (2013)

Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them
par: Ahmed A. Quadeer, et autres
Publié: (2019)

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
par: Yannick Galipeau, et autres
Publié: (2021)

Study on the Clinical Significance of ACE2 and Its Age-Related Expression
par: Gu J, et autres
Publié: (2021)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
par: David R. Martinez, et autres
Publié: (2020)

Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans
par: Xia Xue, et autres
Publié: (2021)

Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers
par: He C, et autres
Publié: (2021)

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
par: Federico Bertoglio, et autres
Publié: (2021)

Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
par: Andrew L Ferguson, et autres
Publié: (2013)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
par: Timothée Bruel, et autres
Publié: (2016)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
par: Ronit Rosenfeld, et autres
Publié: (2021)

Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
par: Christopher A. Cottrell, et autres
Publié: (2021)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
par: Benjamin M. Janus, et autres
Publié: (2018)

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
par: Kizzmekia S. Corbett, et autres
Publié: (2019)

RBD206-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern
par: Chuge Zhou, et autres
Publié: (2021)

A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels
par: Juliano Alves, et autres
Publié: (2021)

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
par: Jinsung Yang, et autres
Publié: (2020)

Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
par: Deli Huang, et autres
Publié: (2020)

Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01
par: Shiyu Sun, et autres
Publié: (2021)

Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells
par: Jeong Hyun Lee, et autres
Publié: (2021)

Revealing the intrinsic superconducting gap anisotropy in surface-neutralized BaFe2(As0.7P0.3)2
par: Ziming Xin, et autres
Publié: (2021)

The glycosylation in SARS-CoV-2 and its receptor ACE2
par: Yanqiu Gong, et autres
Publié: (2021)

Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection
par: Fengling Feng, et autres
Publié: (2021)

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
par: Aimin Tang, et autres
Publié: (2019)

The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor
par: Chuncui Huang, et autres
Publié: (2021)

CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
par: Gang Zhang, et autres
Publié: (2020)